Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
9
×
life sciences
9
×
national blog main
startups
9
×
biotech
san francisco blog main
clinical trials
fda
san francisco top stories
deals
new york blog main
san diego blog main
san diego top stories
boston blog main
cancer
investing
national top stories
new york top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
raleigh-durham blog main
raleigh-durham top stories
roboticsai
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
indiana blog main
indiana top stories
medical device
national
pfizer
san francisco
synthetic biology
What
drug
drugs
bio
roundup
available
biological
biologics
can’t
cells
clears
companies
convenience
digestive
disease
enzymes
fda
humans
hurdle
pill
produce
proteins
rani’s
robotic
survive
swallowing
that’s
therapies
they’re
admits
advance
ago
ahead
alzheimer’s
annual
approved
asco
assessed
attention
babies
bacteria
Language
unset
Current search:
drugs
×
startups
×
" life sciences "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs